Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$1.03B |
| 2 |
iShares Bitcoin Trust
IBIT
|
+$978M |
| 3 |
UnitedHealth
UNH
|
+$636M |
| 4 |
Nasdaq
NDAQ
|
+$575M |
| 5 |
Columbia Research Enhanced Core ETF
RECS
|
+$563M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.57B |
| 2 |
NVIDIA
NVDA
|
+$1B |
| 3 |
iShares Silver Trust
SLV
|
+$754M |
| 4 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$662M |
| 5 |
Microsoft
MSFT
|
+$632M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.3% |
| 2 | Financials | 1.21% |
| 3 | Consumer Discretionary | 1.07% |
| 4 | Industrials | 1.02% |
| 5 | Communication Services | 0.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EPIX
8976
DELISTED
ESSA Pharma
EPIX
| $74.6K | ﹤0.01% |
+43,907
| New | +$74.1K |
|
8977
PUT
Melco Resorts & Entertainment
MLCO
$2.12B
| $74.5K | ﹤0.01% |
+10,300
| New | +$59.9K |
|
8978
Prelude Therapeutics
PRLD
$449M
| $74.3K | ﹤0.01% |
+91,753
| New | +$79.4K |
|
8979
Spectral AI
MDAI
$52.5M
| $73.7K | ﹤0.01% |
+29,728
| New | +$45.8K |
|
8980
CALL
Sana Biotechnology
SANA
$1.1B
| $73.4K | ﹤0.01% |
26,900
+2,200
| +9% | +$4.54K |
|
8981
Bridger Aerospace
BAER
$73.5M
| $73.3K | ﹤0.01% |
+38,000
| New | +$58.4K |
|
|
MREO
8982
CALL
Mereo BioPharma
MREO
$49.9M
| $73.2K | ﹤0.01% |
27,000
+15,100
| +127% | +$36.4K |
|
8983
PUT
Hyliion Holdings
HYLN
$725M
| $72.9K | ﹤0.01% |
+55,200
| New | +$80.4K |
|
8984
CALL
Prospect Capital
PSEC
$1.12B
| $72.8K | ﹤0.01% |
22,900
-8,600
| -27% | -$29.9K |
|
|
CHW
8985
Calamos Global Dynamic Income Fund
CHW
$554M
| $72.5K | ﹤0.01% |
10,166
-23,158
| -69% | -$152K |
|
8986
PUT
SEALSQ Corp
LAES
$651M
| $71.3K | ﹤0.01% |
+17,700
| New | +$54.4K |
|
|
AGEN
8987
PUT
Agenus
AGEN
$320M
| $71.3K | ﹤0.01% |
+15,600
| New | +$54K |
|
8988
PUT
ARKO Corp
ARKO
$535M
| $71.1K | ﹤0.01% |
16,800
+2,900
| +21% | +$12.7K |
|
|
TRUE
8989
DELISTED
TrueCar
TRUE
| $71K | ﹤0.01% |
37,348
-110,583
| -75% | -$169K |
|
8990
PUT
Vor Biopharma
VOR
$1.35B
| $71K | ﹤0.01% |
+2,190
| New | +$19.4K |
|
|
RDNW
8991
RideNow Group
RDNW
$252M
| $70.5K | ﹤0.01% |
+30,531
| New | +$68.6K |
|
|
PWCM
8992
PowerCompute Inc
PWCM
$1.13M
| $70.4K | ﹤0.01% |
+984
| New | +$40.6K |
|
8993
PUT
Microvision
MVIS
$52.8M
| $69.8K | ﹤0.01% |
4,080
-400
| -9% | -$6.93K |
|
8994
CALL
Blend Labs
BLND
$345M
| $69.6K | ﹤0.01% |
21,100
+10,800
| +105% | +$36.6K |
|
8995
Q32 Bio
QTTB
$472M
| $69.5K | ﹤0.01% |
+46,635
| New | +$79.5K |
|
8996
CALL
Maravai LifeSciences
MRVI
$852M
| $69.4K | ﹤0.01% |
+28,800
| New | +$60.5K |
|
8997
UNIFI
UFI
$138M
| $69.3K | ﹤0.01% |
13,273
+16
| +0.1% | +$79 |
|
|
EPIX
8998
CALL
DELISTED
ESSA Pharma
EPIX
| $69K | ﹤0.01% |
+40,600
| New | +$68.5K |
|
8999
Relmada Therapeutics
RLMD
$508M
| $68.6K | ﹤0.01% |
+114,354
| New | +$58.7K |
|
9000
Enlivex Ltd
ENLV
$26.6M
| $68.4K | ﹤0.01% |
4,070
-1,314
| -24% | -$19.5K |
|
Similar funds
Jane Street's Q2 2025 Portfolio in Review
As of Q2 2025, Jane Street held 11,384 positions worth $506B, up 27% from $397B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Jane Street deployed $36.7B of net new capital in Q2 2025, opening 2,110 new positions and adding to 3,865 existing holdings. Its largest new stake was Nasdaq: 7,205,132 shares worth $644M.
By sector, the portfolio is most concentrated in Technology at 2.3% of assets, down from 3.1% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Broadcom, an estimated $1.57B trimmed.
- Jane Street's largest Q2 2025 buy was Nasdaq: 7,205,132 shares worth $644M.
- Jane Street added most to T-Mobile US in Q2 2025, an estimated $1.03B increase.
- Jane Street's biggest Q2 2025 reduction was Broadcom, cutting an estimated $1.57B.
- Jane Street fully exited iShares Core MSCI Total International Stock ETF in Q2 2025, selling an estimated $662M.
- Jane Street's ten largest holdings make up 39% of its $506B portfolio in Q2 2025.
- Jane Street opened 2,110 new positions and closed 1,895 in Q2 2025.
- Jane Street's portfolio value rose 27% quarter-over-quarter to $506B.
Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.